He has been idle and focused on his other businesses for months. Clearly out of his league to head stem cell INDs. Not turning over reigns is a sure way to send this and his patents into other hands...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.